Identification of CK2 as the kinase that phosphorylates Pax3 at Ser209 in early myogenic differentiation

被引:14
作者
Iyengar, Aditi S. [1 ]
Loupe, Jacob M. [1 ]
Miller, Patrick J. [1 ]
Hollenbach, Andrew D. [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA
基金
美国国家卫生研究院;
关键词
Pax3; Myogenesis; CK2; Phosphorylation; PROTEIN-KINASE; CANCER-THERAPY; CELLS;
D O I
10.1016/j.bbrc.2012.09.141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The myogenic transcription factor Pax3, a member of the paired class homeodomain family of transcription factors, plays an essential role in early skeletal muscle development. We previously demonstrated that Pax3 is phosphorylated at three specific residues (Ser201, Ser205, and Ser209) and that the pattern of phosphorylation at these sites changes throughout early myogenesis. Further, we demonstrated that the protein kinase CK2 phosphorylates Pax3 at Ser205 and that this phosphorylation event is required for the subsequent phosphorylation of Ser201 by GSK3 beta. However, the kinase that phosphorylates Pax3 at Ser209 has yet to be identified. In the present work we use standard purification methods and in vitro biochemical analyses to provide solid evidence identifying the protein kinase CK2 as phosphorylating Pax3 at Ser209. Further, we qualitatively demonstrate that the phosphorylation of Pax3 at Ser209 by CK2 is enhanced when Ser205 is previously phosphorylated. Taken together, our results allow us to propose a mechanism to describe the ordered phosphorylation of Pax3 throughout early myogenesis. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 17 条
  • [1] Targeting CK2 for cancer therapy
    Ahmad, KA
    Wang, GX
    Slaton, J
    Unger, G
    Ahmed, K
    [J]. ANTI-CANCER DRUGS, 2005, 16 (10) : 1037 - 1043
  • [2] PROTEIN KINASES .4. PROTEIN-KINASE CK2 - AN ENZYME WITH MULTIPLE SUBSTRATES AND A PUZZLING REGULATION
    ALLENDE, JE
    ALLENDE, CC
    [J]. FASEB JOURNAL, 1995, 9 (05) : 313 - 323
  • [3] Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities
    Amstutz, Ralf
    Wachtel, Marco
    Troxler, Heinz
    Kleinert, Peter
    Ebauer, Margret
    Haneke, Torsten
    Oehler-Jaenne, Christoph
    Fabbro, Doriano
    Niggli, Felix K.
    Schaefer, Beat W.
    [J]. CANCER RESEARCH, 2008, 68 (10) : 3767 - 3776
  • [4] BOBER E, 1994, DEVELOPMENT, V120, P603
  • [5] Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors
    Boutet, Stephane C.
    Disatnik, Marie-Helene
    Chan, Lauren S.
    Iori, Kevin
    Rando, Thomas A.
    [J]. CELL, 2007, 130 (02) : 349 - 362
  • [6] Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse
    Conway, SJ
    Henderson, DJ
    Kirby, ML
    Anderson, RH
    Copp, AJ
    [J]. CARDIOVASCULAR RESEARCH, 1997, 36 (02) : 163 - 173
  • [7] Identification of serines 201 and 209 as sites of Pax3 phosphorylation and the altered phosphorylation status of Pax3-FOXO1 during early myogenic differentiation
    Dietz, Kevin N.
    Miller, Patrick J.
    Lyengar, Aditi S.
    Loupe, Jacob M.
    Hollenbach, Andrew D.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2011, 43 (06) : 936 - 945
  • [8] Phosphorylation of Serine 205 by the Protein Kinase CK2 Persists on Pax3-FOXO1, but Not Pax3, throughout Early Myogenic Differentiation
    Dietz, Kevin N.
    Miller, Patrick J.
    Hollenbach, Andrew D.
    [J]. BIOCHEMISTRY, 2009, 48 (49) : 11786 - 11795
  • [9] Role of Pax3 acetylation in the regulation of Hes1 and Neurog2
    Ichi, Shunsuke
    Boshnjaku, Vanda
    Shen, Yueh-Wei
    Mania-Farnell, Barbara
    Ahlgren, Sara
    Sapru, Sidanth
    Mansukhani, Nikhita
    McLone, David G.
    Tomita, Tadanori
    Mayanil, C. S. K.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2011, 22 (04) : 503 - 512
  • [10] One-thousand-and-one substrates of protein kinase CK2?
    Meggio, F
    Pinna, LA
    [J]. FASEB JOURNAL, 2003, 17 (03) : 349 - 368